Prior COVID-19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case-control study.
Kiavash Semnani, Marjan Sohrabi, Parvaneh Ebrahimi Alavijeh, SeyedAhmad SeyedAlinaghi, Shirin Esmaeili, Farzin Halabchi, Zahra Alizadeh, Amir Salami, Arezoo Salami Khaneshan
Author Information
Kiavash Semnani: Tehran University of Medical Sciences School of Medicine, Tehran, Iran.
Marjan Sohrabi: Department of Infectious Diseases, Tehran University of Medical Sciences, Imam Khomeini Hospital Complex, Tohid Squre, Tehran, Iran.
Parvaneh Ebrahimi Alavijeh: Department of Infectious Diseases, Tehran University of Medical Sciences, Arash Women's Hospital, Tehran, Iran.
SeyedAhmad SeyedAlinaghi: Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Iranian Institute for Reduction of High Risk Behaviors, Tehran, Iran.
Shirin Esmaeili: Tehran University of Medical Sciences School of Medicine, Tehran, Iran.
Farzin Halabchi: Department of Sports and Exercise Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Zahra Alizadeh: Department of Sports and Exercise Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Amir Salami: Student Research Committee, Iran University of Medical Sciences School of Medicine, Hemmat Hwy, Tehran, Iran.
Arezoo Salami Khaneshan: Department of Infectious Diseases, Tehran University of Medical Sciences, Imam Khomeini Hospital Complex, Tohid Squre, Tehran, Iran. ORCID
OBJECTIVE: To assess the risk of developing pulmonary tuberculosis (TB) in accordance with prior history of COVID-19 infection. BACKGROUND: Since the advent of the COVID-19 pandemic much discussion has been had on the possible role it might play on global efforts to combat TB; most, focusing on the pandemic's impact on health care systems' capabilities to manage TB cases. Mechanisms have also been proposed by which the COVID-19 infection may directly affect individuals' chance of developing TB infection. Cases have been reported with a history of COVID-19 infection preceding a diagnosis of TB, evidencing its possible role as a risk factor for the disease. METHODS: A case-control study was conducted enrolling patients diagnosed with pulmonary TB in the absence of major risk factors previous history of TB, (HIV) human immunodeficiency virus infection), end-stage renal disease, organ transplants, and use of immunosuppressive agents) for developing TB. Each patient was age and sex matched with one healthy control. Data regarding prior COVID-19 infection, diabetes, and smoking status as well as the use of corticosteroids and Tocilizumab for the treatment of COVID-19 infection was obtained. Bivariate analysis was conducted and variables with a likely association with TB status were entered in a multivariate model. RESULTS: Bivariate analysis demonstrated a significant relationship between prior COVID-19 infection and TB (95% confidence interval = 1.1-22.8, odds ratio [OR] = 5). Among other variables the severity of COVID-19 infection was found to have a likely association with TB status (p = .125). In a multivariate model, prior COVID-19 infection per se, was not found to be significantly associated with TB (p = .12, OR = 4.5). CONCLUSIONS: There seems to be an association between prior history of COVID-19 and a future diagnosis of TB partially linked to the severity of disease. The findings of the current study may serve as a basis for further studies to determine the need for and efficacy of measures to follow-up COVID-19 patients at an increased risk for developing TB.
